MyFinsight
Home
Blog
About
Cash and cash
equivalents
$13,084,144
(95.46%↑ Y/Y)
Prepaid expenses and
other current assets
$1,675,110
(-27.00%↓ Y/Y)
Tax credits
$210,494
(-33.77%↓ Y/Y)
Operating lease
right-of-use assets
$266,861
(14.43%↑ Y/Y)
Internal-use software, net
$76,782
(-39.95%↓ Y/Y)
Property and equipment,
net
$47,026
(-51.11%↓ Y/Y)
Restricted cash
$35,589
(-1.90%↓ Y/Y)
Long-term deposits and
other noncurrent...
$25,933
(-23.17%↓ Y/Y)
Total current assets
$14,969,748
(60.85%↑ Y/Y)
Total noncurrent
assets
$452,191
(-14.24%↓ Y/Y)
Total assets
$15,421,939
(56.82%↑ Y/Y)
Total liabilities and
stockholders' equity
$15,421,939
(56.82%↑ Y/Y)
Total stockholders'
equity
$11,292,031
(205.52%↑ Y/Y)
Total liabilities
$4,129,908
(-32.71%↓ Y/Y)
Accumulated deficit
-$111,640,310
(-37.50%↓ Y/Y)
Additional paid-in capital
$121,924,254
(28.83%↑ Y/Y)
Total current
liabilities
$3,433,865
(-33.93%↓ Y/Y)
Total noncurrent
liabilities
$696,043
(-26.02%↓ Y/Y)
Accumulated other
comprehensive income
$1,003,752
(71.85%↑ Y/Y)
Common stock, 0.0001
par value...
$4,335
(40.84%↑ Y/Y)
Other current
liabilities
$1,980,444
(-9.94%↓ Y/Y)
Accounts payable
$1,220,365
(-55.02%↓ Y/Y)
Loans - current
$123,628
(-1.97%↓ Y/Y)
Operating lease
liabilities - current
$109,428
(-19.73%↓ Y/Y)
Defined benefit pension
plan
$319,225
(-38.92%↓ Y/Y)
Loans - noncurrent
$220,058
(-32.36%↓ Y/Y)
Operating lease
liabilities - noncurrent
$156,760
(68.83%↑ Y/Y)
Back
Back
Balance Sheet
Gain Therapeutics, Inc. (GANX)
Gain Therapeutics, Inc. (GANX)
source: myfinsight.com